Ingrezza commercial

If ingrezza ad executives are monitoring our posts, then maybe they'll have Tony and Bud together and re-create some classic comedy bits. Here's one Tony and Bud are in ancient Egypt. Tony is holding an ancient vase he just found. He sees a mummy, drops the vase and says "Hey Abbott!"

Commercial/Healthcare Exchange PA Criteria Effective: May, 2017 Prior Authorization: Ingrezza Products Affected: Ingrezza (valbenazine) Medication Description: Ingrezza (valbenazine) is a vesicular monoamine transporter 2 (VMAT2) inhibitor indicated for the treatment of adults with tardive dyskinesia (TD).Depression and Suicidality in Patients with Huntington’s Disease: VMAT2 inhibitors, including INGREZZA, can increase the risk of depression and suicidal thoughts and behavior (suicidality) in patients with Huntington’s disease. Balance the risks of depression and suicidality with the clinical need for treatment of chorea.INGREZZA ® (valbenazine) Third Quarter Net Product Sales of $486 Million Representing 29% Year-Over-Year Growth INGREZZA ® (valbenazine) 2023 Net Product Sales Guidance Raised to $1.82 - $1.84 ...Payer Type: Commercial OtherMedicare Medicaid Patient Does Not Have Insurance Phone: To be completed in full, signed, and dated, then faxed to 844-394-7155. For additional assistance, call 84-INGREZZA (844-647-3992), 8 am – 8 pm EST, M – F. INSTRUCTIONS Patient/Authorized Representative Signature: Date:INGREZZA ® (valbenazine) Fourth Quarter and Full Year 2023 Net Product Sales of $500 Million and $1.84 Billion, Representing Year-over-Year Growth of 25% and 29% Respectively. INGREZZA ...

Ingrezza, the first U.S. Food and Drug Administration (FDA) approved treatment for adults with tardive dyskinesia, is a highly selective vesicular monoamine transporter 2 (VMAT2) inhibitor. The oral therapy works by reducing the release and breakdown of dopamine in a region of the brain that controls movement and motor function, helping to ...Ingrezza is the first and only FDA-approved drug indicated for the treatment of adults with Tardive dyskinesia. Image courtesy of Neurocrine Biosciences. Tardive dyskinesia occurs due to irregular dopamine signalling in brain. The drug regulates monoamine uptake from the cytoplasm to the synaptic vesicle for storage and release.Increase Primarily Driven by Additional Commercial Initiatives to Support INGREZZA Non-GAAP Net Income $158 $125 Increase Driven by Higher INGREZZA Sales Partially Offset by Incremental Operating Expenses Non-GAAP Earnings per Share, Diluted $1.54 $1.24 24% Year-over-Year Growth Cash and Investments (Period End) $1,719 $1,289Many paths, one goal: Access for every patient prescribed INGREZZA® (valbenazine) capsules. ... This offer is valid only for patients with commercial (nongovernment-funded) insurance. Additional terms and conditions apply. Prescribing INGREZZA INGREZZA is available through a dedicated network of pharmacies to deliver the highest level of ...Ingrezza 60 mg capsule. Color: purple,dark red Shape: oblong Imprint: VBZ 60 VBZ 60. This medicine is a purple, oblong, capsule imprinted with "VBZ 80" and "VBZ 80". Look up another drug .a. The KINECT-HD pivotal study was a Phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety, and tolerability of once-daily INGREZZA in subjects with HD chorea. The study included a 4-week screening period, an 8-week dose-adjustment period, a 4-week maintenance period, and a final study visit 2 weeks ...*This offer is valid only for patients with commercial (nongovernment‑funded) insurance. Additional terms and conditions apply. If you have health insurance from your employer, or insurance that you purchased on your own, you may be eligible for the INGREZZA Savings Program. Please see INGREZZA full Prescribing Information, including Boxed ...

So you don't fully understand why this happens, but you're just going to prescribe a drug for it, way to go. These kind of commercials are awful. Ingrezza is life altering for many people with mental illness. Many people don't know the drug exists hence the commercial. This commercial is so bad.The INBRACE® Support Program is designed to help patients who are prescribed INGREZZA® (valbenazine) capsules through a range of financial assistance programs. Most patients pay less than $10 out-of-pocket cost for INGREZZA. INGREZZA coverage is approved for more than 8 of 10 patients nationwide.*. *Measured by NDC; data on file as of Q1 2023.Share this article. SAN DIEGO, April 30, 2024 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the U.S. Food and Drug Administration has approved INGREZZA ® SPRINKLE ...This new drug application provides for the use of Ingrezza (valbenazine) 40mg Capsules for the treatment of tardive dyskinesia. We have completed our review of this application, as amended. It is approved, effective on the date of this letter, for use as recommended in the enclosed agreed-upon labeling text.Ingrezza Alternatives Compared. Ingrezza (valbenazine) Austedo (deutetrabenazine) Propranolol. Prescription only. Ingrezza may be used to treat adults with tardive dyskinesia or chorea associated with Huntington's disease. It works by blocking VMAT2, which reduces the uptake of dopamine by the brain.FDA News Release. FDA approves first drug to treat tardive dyskinesia. For Immediate Release: April 11, 2017. The U.S. Food and Drug Administration today approved Ingrezza (valbenazine) capsules...

Greyhound brunswick ga.

SAN DIEGO, May 21, 2024 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the publication of data from a post hoc analysis of the Phase 3 KINECT ®-4 study of INGREZZA ® (valbenazine) capsules in the Journal of Clinical Psychopharmacology. The analysis assessed long-term outcomes relevant to the real-world management of tardive dyskinesia (TD) and demonstrated that ...It is not known if Ingrezza is safe for children. The most common side effect was sleepiness. Other side effects may include coordination problems, headache, restlessness, dry mouth, constipation, and blurred vision. Serious side effects may include heart rhythm problems and Parkinson-like symptoms.Ingrezza 60 mg capsule. Color: purple,dark red Shape: oblong Imprint: VBZ 60 VBZ 60. This medicine is a purple, oblong, capsule imprinted with "VBZ 80" and "VBZ 80". Look up another drug .The US Food and Drug Administration approved Ingrezza Sprinkle (valbenazine) capsules for the treatment of adults with tardive dyskinesia (TD). Ingrezza Sprinkle is a new oral granules formulation of the medication, which is currently approved for the treatment of TD. 1 The new formulation was also approved for the treatment of …

MDH - September 2023 Ingrezza® (valbenazine) Prior Authorization Form Incomplete forms will not be reviewed Maryland Medicaid Pharmacy Program Fax: (410) 333-5398 Phone: (833) 325-0105Dedicated, field-based experts are available to help you and your office navigate access to INGREZZA ® (valbenazine) capsules for your patients. Neurocrine's Regional Patient Access Managers have expertise in coverage, insurance requirements, and patient support programs, and can offer personalized support on the following: Navigate payer ...INGREZZA demonstrated a three-times greater improvement in chorea severity compared to placebo, with a 4.6-point improvement seen with INGREZZA versus a 1.4-point improvement with placebo in the ...Treatment Options for Tardive Dyskinesia. Changing your medication. Medications for TD. Deep brain stimulation. Botox injections. Supplements used for TD. Lifestyle. Takeaway. Tardive dyskinesia ...Like most other things these days, you can pretty easily find the names of actors in TV commercials through a simple online search. In particular, there are several websites and online resources that specialize in this kind of search. Photo Courtesy: Progressive via YouTube. Here are some of our top recommendations:Check out Ingrezza's 60 second TV commercial, 'Taking on TD' from the Rx: Depression, Bipolar & Insomnia industry. Keep an eye on this page to learn about the songs, characters, and celebrities appearing in this TV commercial. Share it with friends, then discover more great TV commercials on iSpot.tv.Share this article. SAN DIEGO, April 30, 2024 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the U.S. Food and Drug Administration has approved INGREZZA ® SPRINKLE ...Getting a commercial loan is not easy, especially for first-time applicants. The process of applying for a commercial loan will feel very different than any other loan application ...In a clinical study, most people began to experience improvement at 2 weeks.* Significant improvement was shown at 12 weeks vs placebo. † * Patients had at least a 1-point reduction in TMC score at 2 weeks vs before treatment. This post-clinical study evaluation included 64 patients taking INGREZZA 40 mg, measuring HD chorea before starting treatment and at 2 weeks of treatment.INGREZZA is contraindicated in patients with a history of hypersensitivity to valbenazine or any components of INGREZZA. Rash, urticaria, and reactions consistent with angioedema (e.g., swelling of the face, lips, and mouth) have been reported. WARNINGS & PRECAUTIONS Somnolence INGREZZA can cause somnolence. Patients should not perform activities

Cogentin really doesn't treat TD; it can help with other EPS symptoms. Austedo and Ingrezza would be the treatments for TD. I've always been told that Cogentin prevents and/or treats Tardive Dyskinesia. But the Austedo commercial I saw claims to be the first treatment for….

SAN DIEGO, May 21, 2024 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the publication of data from a post hoc analysis of the Phase 3 KINECT ®-4 study of INGREZZA ...INGREZZA® (valbenazine) capsules HCP. 63 followers. 6mo. Please see Important Safety Information, including Boxed Warning, below and INGREZZA full Prescribing Information at: https://lnkd.in/dMfy ...Please see Important Safety Information, including Boxed Warning, below.Hear about the efficacy, safety profile, and dosing schedule of a treatment for adult...Approved Uses. INGREZZA® (valbenazine) capsules or INGREZZA® SPRINKLE (valbenazine) capsules are prescription medicines used to treat adults with: movements in the face, tongue, or other body parts that cannot be controlled (tardive dyskinesia). involuntary movements (chorea) of Huntington’s disease. INGREZZA or INGREZZA SPRINKLE do not ...Approved Uses. INGREZZA® (valbenazine) capsules or INGREZZA® SPRINKLE (valbenazine) capsules are prescription medicines used to treat adults with: movements in the face, tongue, or other body parts that cannot be controlled (tardive dyskinesia). involuntary movements (chorea) of Huntington’s disease.Tv spot - Different Light Recut. 739 July 10, 2022. Title: Ingrezza TV Spot, 'Different Light Recut'Introduction:The world of advertising is constantly evolving, and every now and then, an ad campaign comes along that challenges the norms and leaves a lasting impression. One such campaign is the Ingrezza TV Spot, titled 'Different Light Recut.'.Ingrezza; Descriptions. Valbenazine is used to treat movement disorders, including tardive dyskinesia and chorea caused by Huntington's disease. ... Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes. Share; Tweet; Advertisement. Mayo Clinic does not endorse companies or …Mumbai, Naples, April 8,2024: Global pharma major Lupin Limited (Lupin) today announced that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA) for Valbenazine Capsules, 40 mg and 80 mg, to market a generic equivalent of Ingrezza® Capsules, 40 mg and 80 mg, of ...

Coors field ticket map.

Jobs in everett wa craigslist.

Microsoft Word - Medication Policy_Ingrezza_2022_12_12. Generic Name: Valbenazine. Therapeutic Class or Brand Name: Ingrezza. Applicable Drugs (if Therapeutic Class): N/A. Preferred: N/A.Not so much hate the commercial but the petty people on it. The INGREZZA for 'mental health' that causes small tics. All one lady does is take her tongue like she digging for a popcorn hull and the people look at her like she's Quasimodo. This thread is archivedPronunciation of the word(s) "Ingrezza". Channel providing free audio/video pronunciation tutorials in English and many other languages. The videos cover a d...Ingrezza Enrollment Form is a document used by healthcare professionals or patients to initiate the enrollment process for accessing Ingrezza medication. Ingrezza (valbenazine) is a prescription medication indicated for the treatment of tardive dyskinesia, a movement disorder. The enrollment form gathers necessary information such as patient ...Cogentin really doesn't treat TD; it can help with other EPS symptoms. Austedo and Ingrezza would be the treatments for TD. I've always been told that Cogentin prevents and/or treats Tardive Dyskinesia. But the Austedo commercial I saw claims to be the first treatment for….constipation. joint pain. blurry vision. weight gain*. nausea or vomiting *. dry mouth *. * For more information about this side effect, see the “Side effect focus” section below. Mild side ...Administer INGREZZA orally with or without food [see Clinical Pharmacology (12.3)]. Tardive Dyskinesia The initial dosage for INGREZZA is 40 mg once daily. After one week, increase the dose to the recommended dosage of 80 mg once daily. A dosage of 40 mg or 60 mg once daily may be considered depending on response and tolerability.* This offer is valid only for patients with commercial (nongovernment-funded) insurance. Additional terms and conditions apply. If you are eligible, a Savings Card may be applied automatically at the pharmacy, which may help you save money on your INGREZZA prescription. Call the INGREZZA Call Center at 1-84-INGREZZA (1-844-647-3992)How well do you know the TV commercials that helped define the 1990s? Find out with our HowStuffWorks quiz. Advertisement Advertisement Advertisement Advertisement Advertisement Ad...Its molecular formula is C38H54N2O10S2, and its molecular weight is 762.97 g/mol (ditosylate salt) with the following structure: The molecular formula of valbenazine free base is C24H38N2O4 and its molecular weight is 418.57. INGREZZA capsules are intended for oral administration only.The INGREZZA for 'mental health' that causes small tics. All one lady does is take her tongue like she digging for a popcorn hull and the people look at her like she's Quasimodo. ... Never liked this commercial. They used to have a country singer sing the song, now they replaced it with H.E.R and it still sucks. ...Approved Uses. INGREZZA® (valbenazine) capsules or INGREZZA® SPRINKLE (valbenazine) capsules are prescription medicines used to treat adults with: movements in the face, tongue, or other body parts that cannot be controlled (tardive dyskinesia). involuntary movements (chorea) of Huntington’s disease. INGREZZA or INGREZZA SPRINKLE do not ... ….

*This offer is valid only for patients with commercial (nongovernment-funded) insurance. Additional terms and conditions apply. INGREZZA coverage is ...In the 3 placebo-controlled clinical studies in patients with TD, the incidence of parkinson-like adverse events was 3% of patients treated with INGREZZA and <1% of patients treated with placebo. The mean change in Simpson-Angus Scale score from baseline at 6 weeks across studies was 1, 3, f: 0.0 for INGREZZA 40 mg. −0.1 for INGREZZA 80 mg.Commercial truck insurance is important because there are many truck accidents every year. It is not only mandatory for truckers to have insurance, it’s mandatory for them to maint...Get free Ingrezza coupons instantly and save up to 80%. See the cheapest pharmacy price and start saving on Ingrezza today. Mobile App Providers Blog Help. ... The discount coupons offered by RxSaver are intended for out-of-pocket paying consumers and may not be used with commercial health plans or any federal or state funded health care ...Dosage for tardive dyskinesia. Ingrezza is approved to treat tardive dyskinesia in adults. The usual dosage for this indication is as follows: Starting dosage: 40 mg once per day. Maintenance ...INGREZZA® (valbenazine) capsules or INGREZZA® SPRINKLE (valbenazine) capsules are prescription medicines used to treat adults with: movements in the face, tongue, or other body parts that cannot be controlled (tardive dyskinesia). involuntary movements (chorea) of Huntington’s disease. INGREZZA or INGREZZA SPRINKLE do not cure the cause of ...INGREZZA dosages approved for use are 40 mg, 60 mg and 80 mg capsules. INGREZZA is not approved in any other dosage form. Important Information. Approved Uses. INGREZZA ® (valbenazine) capsules is a prescription medicine used to treat adults with: movements in the face, tongue, or other body parts that cannot be controlled …Check out Ingrezza's 60 second TV commercial, 'Impressions' from the Rx: Depression, Bipolar & Insomnia industry. Keep an eye on this page to learn about the songs, characters, and celebrities appearing in this TV commercial. Share it with friends, then discover more great TV commercials on iSpot.tv. Published. January 16, 2023. Ingrezza commercial, Efficacy of INGREZZA 60 mg Based on modeling and simulation, the predicted mean change from baseline in the AIMS dyskinesia total score at Week 6 for INGREZZA 60 mg once daily in subjects with TD is -2.69 (95% CI: -3.30, -2.13), which is within the efficacy range for INGREZZA 40 mg and 80 mg once daily., Ingrezza is called a vmat2 inhibitor and it's sole purpose is to block dopamine in an attempt to stop tardive dyskinesia and chorea. The biggest side effect? Parkinsonism and tremors. It's a very powerful and dirty drug. It's also about $10,000 a month without insurance. My best bet is an Ingrezza rep dropped by his/her office recently., , By blocking VMAT2, Ingrezza reduces the uptake of dopamine, causing a decrease in symptoms of TD and chorea. Ingrezza may also regulate the uptake of other neurotransmitters, such as noradrenaline and serotonin. All these neurotransmitters have various functions within the body but dopamine, in particular, plays a role in movement as well as ..., The program includes copay assistance for individuals with commercial insurance as well as assistance for uninsured patients. The FDA’s decision comes about eight months after the agency agreed to review the company’s application asking to add Huntington’s-associated chorea to Ingrezza ’s label, which already covered tardive …, , SAN DIEGO, May 21, 2024 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the publication of data from a post hoc analysis of the Phase 3 KINECT ®-4 study of INGREZZA ..., INGREZZA is the only treatment proven to reduce TD that's always one capsule, once daily—and it's #1 prescribed. People taking INGREZZA for TD can stay on their current dose of most mental health medications. You can use this guide to help stay the course with your treatment and for motivatING you on your treatment journey., INGREZZA® (valbenazine) capsules or INGREZZA® SPRINKLE (valbenazine) capsules are prescription medicines used to treat adults with: movements in the face, tongue, or other body parts that cannot be controlled (tardive dyskinesia). involuntary movements (chorea) of Huntington's disease. INGREZZA or INGREZZA SPRINKLE do not cure the cause of ..., Tardive dyskinesia (TD) is a neurological disorder caused by the long-term use of neuroleptic drugs, or anti-psychotic medications. Characteristics of the disorder may include frowning, tongue sticking out, rapid eye blinking, and rapid movements of the arms, legs, and trunk. Severe cases may involve problems such as difficulty swallowing ..., INGREZZA ® (valbenazine) 2021 Net Product Sales of $1.1 Billion with 200,000 TRx. INGREZZA ® (valbenazine) 2022 Net Product Sales Guidance of $1.25 - $1.35 Billion. Expanded Pipeline Expected to Deliver Multiple Registrational and Phase 2 Study Data Readouts Over the Next Two Years. SAN DIEGO, Feb. 11, 2022 - …, Real-Time Ad Measurement Across Linear and CTV. TV Ad Attribution & Benchmarking. Marketing Stack Integrations and Multi-Touch Attribution. Real-Time Video Ad Creative Assessment. Ingrezza claims that its once-daily medication can help to diminish the side effects of Tardive Dyskinesia, or TD., TV Ad Attribution & Benchmarking. Marketing Stack Integrations and Multi-Touch Attribution. Real-Time Video Ad Creative Assessment. Ingrezza is a prescribed oral medication which is intended to treat adults who suffer from tardive dyskinesia by reducing dopamine signaling when taken regularly as suggested. Published., TV Ad Attribution & Benchmarking. Marketing Stack Integrations and Multi-Touch Attribution. Real-Time Video Ad Creative Assessment. Ingrezza is a prescribed oral medication which is intended to treat adults who suffer from tardive dyskinesia by reducing dopamine signaling when taken regularly as suggested. Published., Valbenazine is a prodrug which is an ester of [+]-α- dihydrotetrabenazine (DTBZ) with the amino acid L - valine. It is extensively hydrolyzed to the active metabolite DTBZ. Plasma protein binding of valbenazine is over 99%, and that of DTBZ is about 64%. The biological half-life of both valbenazine and DTBZ is 15 to 22 hours., Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced interim results from the ongoing open-label KINECT®-HD2 study about INGREZZA® (valbenazine) capsules when used for the long-term ..., Administer INGREZZA orally with or without food [see Clinical Pharmacology (12.3)]. Tardive Dyskinesia The initial dosage for INGREZZA is 40 mg once daily. After one week, increase the dose to the recommended dosage of 80 mg once daily. A dosage of 40 mg or 60 mg once daily may be considered depending on response and tolerability., Drug Mart is a limited distribution network pharmacy approved to fill your Ingrezza prescription. Click here to learn how we can help if you have been prescribed Ingrezza. And more. Drug Mart also stocks medications for cancer, multiple sclerosis, gastroenterology and cardiology. Transfer your prescription today to let us take care of you., swelling of your face, lips, tongue, or throat, extreme drowsiness, fast, slow, or uneven heartbeats, pounding heartbeats, fluttering in your chest, shortness of breath, and. lightheadedness. Get medical help right away, if you have any of the symptoms listed above. Common side effects of Ingrezza include:, INGREZZA may cause serious side effects, including: Sudden swelling from an allergic reaction (angioedema). Sudden swelling has happened after the first dose or after many doses of INGREZZA. Signs ..., In the world of commercial real estate, finding the right property can be a daunting task. However, thanks to advancements in technology, there are now online platforms that make t..., INGREZZA ® (valbenazine) capsules is a prescription medicine used to treat adults with movements in the face, tongue, or other body parts that cannot be controlled (tardive dyskinesia)., INGREZZA may cause serious side effects, including: Sudden swelling from an allergic reaction (angioedema). Sudden swelling has happened after the first dose or after many doses of INGREZZA. Signs ..., Guggenheim has upgraded Neurocrine Biosciences ( NASDAQ: NBIX) to buy from neutral citing the growth of tardive dyskinesia treatment Ingrezza (valbenazine) and the company's pipeline. The firm ..., Support for every step of the way. The INBRACE ® Support Program is here to support you and is designed to help guide you through your treatment with INGREZZA ® (valbenazine) capsules. We are here to help you every step of the way—from letting you know what to expect when your doctor sends your INGREZZA prescription to the pharmacy, to ..., You should consult your health care professional before taking any drug, changing your diet, or commencing or discontinuing any course of treatment. Valbenazine is used to treat involuntary movements of the face, tongue, or other body parts (tardive dyskinesia). This medication is also used to decr., Pharmacist Instructions: For SECONDARY claims, process a Coordination of Benefits (COB) using the patient’s commercial prescription insurance for the PRIMARY claim. Submit the Secondary claim under BIN: 610020/PCN: PDMI. For Pharmacy processing questions, please call 1-844-784-1777. $. monthly 0 prescription. For assistance:, Many paths, one goal: Access for every patient prescribed INGREZZA® (valbenazine) capsules. ... This offer is valid only for patients with commercial (nongovernment-funded) insurance. Additional terms and conditions apply. Prescribing INGREZZA INGREZZA is available through a dedicated network of pharmacies to deliver the highest level of ..., Fourth Quarter and Fiscal 2022 INGREZZA Net Product Sales and Commercial Highlights:. INGREZZA fourth quarter and fiscal 2022 net product sales were $399 million and $1.43 billion, respectively; INGREZZA fourth quarter net product sales and total prescriptions grew 33% and 29%, respectively, vs. fourth quarter of 2021, With these two indications, Ingrezza became Neurocrine’s top-selling asset. In 2023, the drug brought in $1.84 billion, accounting for almost all of the biotech’s overall revenue of nearly $1.89 billion. For 2024, Neurocrine expects Ingrezza to generate between $2.1 billion and $2.2 billion in sales., Ingrezza 60 mg capsule. Color: purple,dark red Shape: oblong Imprint: VBZ 60 VBZ 60. This medicine is a purple, oblong, capsule imprinted with "VBZ 80" and "VBZ 80". Look up another drug ., The INBRACE® Support Program is designed to help patients who are prescribed INGREZZA® (valbenazine) capsules through a range of financial assistance programs. Most patients pay less than $10 out-of-pocket cost for INGREZZA. INGREZZA coverage is approved for more than 8 of 10 patients nationwide.*. *Measured by NDC; data on file as of Q1 2023., SAN DIEGO , April 30, 2024 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the U.S. Food and Drug Administration has approved INGREZZA ® SPRINKLE (valbenazine) capsules, a new oral granules formulation of INGREZZA ® (valbenazine) capsules prescribed for the treatment of